Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Latest reported ALGS revenue for 2026-06-30 was $2.8M. Net income was -$24.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALGS currently screens at market cap $44.1M.
Use this ALGS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ALGS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ALGS SEC filings page. Lician reads the product cache first so this HTML stays unique to Aligos Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ALGS income, balance, and cash tables.